Sponsor intelligence · INDUSTRY
Clinical trials sponsored by
Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics.
Real, source-linked trial activity for Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics: 2 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Jun 21, 2026. Source-linked, daily-refreshed.
PHASE3 2
Newest Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | A Study of Aleniglipron in Adults With Obesity or Overweight and Type | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 4d ago | Efficacy and Safety of Aleniglipron in Participants With Obesity or Ov | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Gasherbrum Bio, Inc., A Wholly Owned Subsidiary Of Structure Therapeutics (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.